TARRYTOWN, NY — The federal government has accused Regeneron Pharmaceuticals Inc., which is based in Tarrytown, of fraudulently inflating Medicare reimbursement for one of its drugs. The U.S ...

Shares of Regeneron fell 1.2% after hours. The Justice Department’s allegations stem from the way Regeneron subsidizes ...

Medicare Part D – a voluntary outpatient prescription drug benefit – paid more than $25 billion for Eylea between 2012 and 2023, according to the government. “Regeneron greatly inflated the ...

Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...

Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...